Shareholder Proposals at Life Science Companies Key Trends of 2023

4 minute read | July.10.2023

Shareholders in life science companies made a range of proposals this year, including several related to political activity and public disclosure, access to the COVID-19 vaccine and how patent exclusivity may affect product access.

Orrick’s J.T. Ho, Bobby Bee and Crystal Milo explore key trends in those three categories of proposals in a post for The Corporate Counsel’s Proxy Season blog. They examine shareholder proposals that requested reports on:

  • Alignment between lobbying activity or political spending and support for affordable access to healthcare.
  • Actions to ensure greater access to the COVID-19 vaccine.
  • The impact of extended patent exclusivities on product access.